Benzydamine flufenamate

Drug Profile

Benzydamine flufenamate

Alternative Names: Agilona

Latest Information Update: 19 Sep 2013

Price : $50

At a glance

  • Originator Vinas
  • Class Dimethylamines; Fenamates; Indazoles; Nonsteroidal anti-inflammatories; Propanolamines; Small molecules
  • Mechanism of Action Cyclooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

    No
  • New Molecular Entity No

Highest Development Phases

  • Market Withdrawal Inflammation; Musculoskeletal pain

Most Recent Events

  • 01 Jan 2008 Withdrawn for Musculoskeletal pain in Spain (Topical)
  • 01 Jan 2008 Withdrawn for Inflammation in Spain (Topical)
  • 31 Dec 2000 Launched for Inflammation in Spain (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top